We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Donor Platelet Activation Varies by Time of Day

By LabMedica International staff writers
Posted on 13 Jun 2022
Print article
Image: Scanning electron micrographs of non-activated and activated platelets (Photo courtesy of Canadian Blood Services)
Image: Scanning electron micrographs of non-activated and activated platelets (Photo courtesy of Canadian Blood Services)

Platelets, are anucleate cells produced by megakaryocytes in the bone marrow that circulate in the bloodstream for about 10 days. Circulating platelets play a central role in the hemostatic response to vascular injury. They are also involved in maintaining vascular integrity and contributed to immune and inflammatory responses.

Platelet donors, like whole blood and plasma donors, are considered to be one of the healthiest groups of the general population. A number of factors may influence the in vivo platelet activation state in healthy individuals. In particular, platelet activation has been shown to vary according to the time of day, with the highest measured levels during the morning hours.

Hematologist at the Akershus University Hospital (Lørenskog, Norway) collected whole blood samples from 86 platelet donors presenting at their Blood Bank between April 2019 and February 2020. The mean age was 50.8 ± 9.7 years with 56% of donors were female. Samples were collected from the attached sampling bags (containing 42 mL whole blood collected immediately before plateletpheresis) using standard vacutainers. A blood sample was collected into a citrated tube for flow cytometric determination of platelet surface P-selectin expression.

For flow cytometry, 100 µL of citrated blood (diluted 1:20 with phosphate-buffered saline [PBS] containing 0.1% bovine serum albumin [BSA], pH 7.4) was incubated at room temperature with FITC-conjugated anti-CD61 (5 µL) and PE-conjugated anti-CD62P (10 µL) for 15 minutes. Background fluorescence was assessed by labeling diluted samples with 10 µL PE-conjugated isotype control antibody. After incubating, the samples were diluted to 4 mL with PBS/BSA and analyzed immediately on a FACS Canto II flow cytometer (BD Bioscience, San Jose, CA, USA). The percentage of activated platelets (i.e., CD61 and CD62P double-positive platelets) was obtained from a total of 10,000 recorded events with the CD61+ gate.

The investigators reported that the percentage of activated (i.e., P-selectin-expressing) platelets in pre-donation blood samples ranged from 0.2% to 7.5% (1.85 ± 1.57%; median, 1.3%; IQR, 0.8–2.3%). Twenty-seven donors (32%) had less than 1.0% activated platelets, and five donors (6%) had more than 5.0% activated platelets, indicating considerable donor variability in the levels of circulating activated platelets.

The percentage of activated platelets was significantly and inversely correlated with the collection time (i.e., the time of day blood samples were collected) and positively correlated to mean platelet volume (MPV). A weaker positive correlation was also observed with ABO blood group. Analysis of the collection time as a categorical variable showed a greater degree of activated platelets in samples collected between 08:00 and 10:00 than in samples collected during the hours after 10:00 to 14:00 (2.5 ± 1.8 versus 1.1 ± 0.74).

The authors concluded that their results showed that platelet activation was significantly and inversely associated with the collection time by univariate analysis and after adjustment for covariates. The study also showed that blood group A was associated with higher platelet activation. This work may have implications for optimizing the timing of platelet donation, if, for example, the temporal variation in platelet activation at the time of donation can impact the final heterogeneity of the stored platelet concentrates and, potentially, transfusion outcomes. The study was published on June 3 2022 in the Journal of Blood Medicine.

Related Links:
Akershus University Hospital 
BD Bioscience 

Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Total 25-Hydroxyvitamin D₂ & D₃ Assay
Total 25-Hydroxyvitamin D₂ & D₃ Assay
New
Immunofluorescence Analyzer
MPQuanti

Print article

Channels

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.